Devicemaker launches bone void filler for orthopedic surgeries

Emma Brauer -   Print  |
Listen
Text
  • Small
  • Medium
  • Large

Medical device manufacturer Orthofix Medical is launching its Opus MG Set, a synthetic bone void filler for orthopedic surgeries, the company said Sept. 21.

Available as a mold or injection, the magnesium-based Opus MG Set is meant to fill in nonstructural bone voids or gaps during orthopedic procedures, providing a scaffolding to support the natural bone-healing process after a surgery.

Orthofix said the magnesium base is integral to Opus' efficacy, as after the magnesium compound crystallizes, it promotes "high compressive strength," osteogenic cell growth and new bone formation and regeneration.

"Opus Mg Set is yet another example of our commitment to innovative biologic solutions that will meet the needs of our valued surgeon customers and their patients," Orthofix President and CEO Jon Serbousek said in the news release.

Lewisville, Texas-based Orthofix's product portfolio is focused on spine and orthopedic devices.

Copyright © 2021 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

Featured Webinars

Featured Whitepapers

Featured Podcast